drugset / Trial / NCT06508762
A Study to Evaluate the Relative Bioavailability and Food Effect of a New Tablet Formulation of VX-993
NaCrossoverOpen-labelTreatment
Summary
The purpose of the study is to evaluate the pharmacokinetics (PK), safety, and tolerability of VX-993 in healthy adult participants.
Timeline
- Start
- 2024-07-26
- Primary completion
- 2024-09-10
- Completion
- 2024-09-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | VX-993 | Unknown | — | Oral |
Indications
No indication recorded.